Austin, TX · Founded 2020 · Privately Held (backing)
Manufacturer of an optical processor designed to bypass the resistive losses of pushing currents through circuits to gain efficiency. Neurophos is based in Austin, TX and was founded in 2020. It was valued at $310 million at its Series A in Jan 2026, the last priced event on record. It has raised $119 million across 5 recorded rounds; the latest was a $109 million Series A in Jan 2026.
PMV mark · valuation
$310.0M
Oct 2026
Priced at
its Series A
Jan 2026
Total raised
$119.2M
Last round
Later Stage VC (Series A)
Jan 2026
No prints on record
No secondary trades in Neurophos shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Neurophos with a free account
·Post-money valuations for 4 rounds
·The complete investor list: 29 names
·Watch Neurophos: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Neurophos stock.
